First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study von BERGH, Jonas, BONDARENKO, Igor M, CHAN, Arlene, DELALOGE, Suzette, XIN HUANG, KERN, Kenneth A, GIORGETTI, Carla, LICHINITSER, Mikhail R, LILJEGREN, Annelie, GREIL, Richard, VOYTKO, Nataliya L, MAKHSON, Anatoly N, CORTES, Javier, LORTHOLARY, Alain, BISCHOFF, Joachim

Volltext

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer von Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Garnett, Sally, Lindemann, Justin P O, Sapunar, Francisco, Martin, Miguel

Volltext

Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial von Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel

Volltext

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HE... von Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Lluch, Ana, PhD, Tjulandin, Sergei, MD, Zambetti, Milvia, MD, Moliterni, Angela, MD, Vazquez, Federico, MD, Byakhov, Mikhail J, PhD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belen, MD, Mansutti, Mauro, MD, Bozhok, Alla, PhD, Magazzù, Domenico, PhD, Heinzmann, Dominik, PhD, Steinseifer, Jutta, PhD, Valagussa, Pinuccia, BS, Baselga, Jose, MD

Volltext

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-... von YARDLEY, Denise A, ISMAIL-KHAN, Roohi R, MELICHAR, Bohuslav, LICHINITSER, Mikhail, MUNSTER, Pamela N, KLEIN, Pamela M, CRUICKSHANK, Scott, MILLER, Kathy D, LEE, Min J, TREPEL, Jane B

Volltext

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study von Stopeck, Alison T, Lipton, Allan, Body, Jean-Jacques, Steger, Guenther G, Tonkin, Katia, de Boer, Richard H, Lichinitser, Mikhail, Fujiwara, Yasuhiro, Yardley, Denise A, Viniegra, María, Fan, Michelle, Jiang, Qi, Dansey, Roger, Jun, Susie, Braun, Ada

Volltext

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial von AJANI, Jaffer A, RODRIGUEZ, Wuilbert, BODOKY, Gyorgy, MOISEYENKO, Vladimir, LICHINITSER, Mikhail, GORBUNOVA, Vera, VYNNYCHENKO, Ihor, GARIN, August, LANG, Istvan, FALCON, Silvia

Volltext

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study von SALTZ, Leonard B, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, CASSIDY, Jim, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando

Volltext

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the... von Gianni, Luca, Dr, Eiermann, Wolfgang, MD, Semiglazov, Vladimir, MD, Manikhas, Alexey, MD, Lluch, Ana, MD, Tjulandin, Sergey, MD, Zambetti, Milvia, MD, Vazquez, Federico, MD, Byakhow, Mikhail, MD, Lichinitser, Mikhail, MD, Climent, Miguel Angel, MD, Ciruelos, Eva, MD, Ojeda, Belén, MD, Mansutti, Mauro, MD, Bozhok, Alla, MD, Baronio, Roberta, MSci, Feyereislova, Andrea, MD, Barton, Claire, MD, Valagussa, Pinuccia, Baselga, Jose, MD

Volltext

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer von CASSIDY, Jim, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, SALTZ, Leonard, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando

Volltext

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label... von Ismael, Gustavo, Dr, Hegg, Roberto, MD, Muehlbauer, Susanne, PhD, Heinzmann, Dominik, PhD, Lum, Bert, PharmD, Kim, Sung-Bae, MD, Pienkowski, Tadeusz, MD, Lichinitser, Mikhail, MD, Semiglazov, Vladimir, MD, Melichar, Bohuslav, MD, Jackisch, Christian, Prof

Volltext

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer von Stephen Johnston, John Pippen, Jr, Xavier Pivot, Mikhail Lichinitser, Saeed Sadeghi, Veronique Dieras, Henry Leonidas Gomez, Gilles Romieu, Alexey Manikhas, M. John Kennedy, Michael F. Press, Julie Maltzman, Allison Florance, Lisa O'Rourke, Cristina Oliva, Steven Stein, Mark Pegram

Volltext

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRA... von Grob, Jean Jacques, Prof, Amonkar, Mayur M, PhD, Karaszewska, Boguslawa, MD, Schachter, Jacob, Prof, Dummer, Reinhard, Prof, Mackiewicz, Andrzej, Prof, Stroyakovskiy, Daniil, MD, Drucis, Kamil, MD, Grange, Florent, MD, Chiarion-Sileni, Vanna, MD, Rutkowski, Piotr, Prof, Lichinitser, Mikhail, Prof, Levchenko, Evgeny, MD, Wolter, Pascal, MD, Hauschild, Axel, Prof, Long, Georgina V, MD, Nathan, Paul, MD, Ribas, Antoni, Prof, Flaherty, Keith, MD, Sun, Peng, PhD, Legos, Jeffrey J, PhD, McDowell, Diane Opatt, MD, Mookerjee, Bijoyesh, MD, Schadendorf, Dirk, Prof, Robert, Caroline, MD

Volltext

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01) von Pestalozzi, Bernhard C, Prof, Holmes, Eileen, PhD, de Azambuja, Evandro, MD, Metzger-Filho, Otto, MD, Hogge, Laurence, MSc, Scullion, Matt, PhD, Láng, István, Prof, Wardley, Andrew, MD, Lichinitser, Mikhail, MD, Sanchez, Roberto I Lopez, MD, Müller, Volkmar, Prof, Dodwell, David, MD, Gelber, Richard D, Prof, Piccart-Gebhart, Martine J, Prof, Cameron, David, Prof

Volltext

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-... von HOWELL, Anthony, ROBERTSON, John F. R, OSBORNE, C. Kent, ABRAM, Paul, LICHINITSER, Mikhail R, ELLEDGE, Richard, BAJETTA, Emilio, WATANABE, Toru, MORRIS, Charles, WEBSTER, Alan, DIMERY, Isaiah

Volltext

Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial von Eggermont, Alexander M. M., Kicinski, Michal, Blank, Christian U., Mandalà, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew Mark, Lichinitser, Mikhail, Khattak, Muhammad, Carlino, Matteo S., Sandhu, Shahneen Kaur, Puig, Susana, Ascierto, Paolo Antonio, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Van Akkooi, Alexander Christopher Jonathan, Robert, Caroline, Suciu, Stefan

Volltext

First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and... von UNTCH, Michael, MUSCHOLL, Michael, HARBECK, Nadia, JACKISCH, Christian, MÜLLER, Volkmar, PAUSCHINGER, Matthias, THOMSSEN, Christoph, LEHLE, Michaela, CATALANI, Olivier, LÜCK, Hans-Joachim, TJULANDIN, Sergei, JONAT, Walter, MEERPOHL, Hans-Gerd, LICHINITSER, Mikhail, MANIKHAS, Alexey G, COUMBOS, Alexandra, KREIENBERG, Rolf, DU BOIS, Andreas

Volltext

An attempt to prevent senescence: A mitochondrial approach von Skulachev, Vladimir P., Anisimov, Vladimir N., Antonenko, Yuri N., Bakeeva, Lora E., Chernyak, Boris V., Erichev, Valery P., Filenko, Oleg F., Kalinina, Natalya I., Kapelko, Valery I., Kolosova, Natalya G., Kopnin, Boris P., Korshunova, Galina A., Lichinitser, Mikhail R., Obukhova, Lidia A., Pasyukova, Elena G., Pisarenko, Oleg I., Roginsky, Vitaly A., Ruuge, Enno K., Senin, Ivan I., Severina, Inna I., Skulachev, Maxim V., Spivak, Irina M., Tashlitsky, Vadim N., Tkachuk, Vsevolod A., Vyssokikh, Mikhail Yu, Yaguzhinsky, Lev S., Zorov, Dmitry B.

Volltext

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology von Garnett, Sally Anne, Martin, Miguel, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iva, Lichinitser, Mikhail R., Pendergrass, Kelly, Lindemann, Justin P. O., Di Leo, Angelo

Volltext

Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level von Vartanian, Amalia A, Burova, Olga S, Stepanova, Eugeniya V, Baryshnikov, Anatoly Yu, Lichinitser, Mikhail R

Volltext